Resources

 

Medscape CME

 
 

Featured CME

 
  • CME FDA Safety Changes: Ambien, Primaxin IM/IV, Hepsera The FDA has approved revisions to the safety labeling for zolpidem tartrate, imipenem-cilastatin intramuscular injection, imipenem-cilastatin intravenous infusion, and adefovir dipivoxil.
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.